Strength

236; 2.97; 6.74; 5.86; 22.74 g/4L; g/4L; g/4L; g/4L; g/4L

NDC

52268010001

Classification

Brand

Dosage Form

POWDER, FOR SOLUTION

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA019011

On Market Since

7/13/1984

Pharmacological Classes

Increased Large Intestinal Motility
Increased Large Intestinal Motility
Increased Large Intestinal Motility
Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Activity
Osmotic Activity
Osmotic Activity
Osmotic Activity
Osmotic Laxative
Osmotic Laxative
Osmotic Laxative
Osmotic Laxative
Osmotic Laxative
Potassium Compounds
Potassium Salt
Stimulation Large Intestine Fluid/Electrolyte Secretion

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-0.2%

1Y

0.0%

3Y

-0.3%

5Y

+75.3%

All

+45.0%